MO43156: A clinical trial to look at how well atezolizumab works (and how safe the drug is) in people with inoperable locally advanced non‑small cell lung cancer (NSCLC), whose cancer has not got worse after radiotherapy and platinum-based chemotherapy given together (ASTRES)

A clinical trial to look at how well atezolizumab works (and how safe the drug is) in people with inoperable locally advanced non-small cell lung cancer (NSCLC), whose cancer has not got worse after radiotherapy and platinum-based chemotherapy given together

Cancer
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)

Results
Download

Study results

LPS MO43156 ASTRES Final Results May 2026 English (PDF, 0.6 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

MO43156: A clinical trial to look at how well atezolizumab works (and how safe the drug is) in people with inoperable locally advanced non‑small cell lung cancer (NSCLC), whose cancer has not got worse after radiotherapy and platinum-based chemotherapy given together (ASTRES)

Study results

LPS MO43156 ASTRES Final Results May 2026 English (PDF, 0.6 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

Thank you

Request a call back

Find participating medical centers and current study status in each of them

MO43156: A clinical trial to look at how well atezolizumab works (and how safe the drug is) in people with inoperable locally advanced non‑small cell lung cancer (NSCLC), whose cancer has not got worse after radiotherapy and platinum-based chemotherapy given together (ASTRES)

For the latest version of this information please go to www.forpatients.roche.com